The European healthcare technology and medical technology sectors have entered a period of definitive industrial maturity as of early 2026. This era is characterised by a fundamental shift away from the liquidity-fueled exuberance of the early 2020s toward a disciplined, metrics-driven environment where strategic value is defined by clinical utility, regulatory resilience, and technological defensibility. Within this landscape, the role of financial advisory has undergone a r

This report provides an analysis of the advisory landscape available to European VC-backed founders. It draws upon extensive market data, deal logs, and industry reports to categorize and evaluate the leading financial advisors. Conversely, "Digital Health" assets, valued on recurring revenue and algorithmic defensibility, are increasingly served by specialised technology boutiques such as Arma Partners, Clipperton and Nelson Advisors.